Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Quantification of Fusion Transcripts Reveals Slower Treatment Kinetics As Compared with Multiparameter Flow Cytometry during Induction Treatment of Acute Myeloid Leukemia in Children

Lene Karlsson, MD, Charlotte Guldborg Nyvold, Lars Palmqvist, Professor, Anne Tierens, MD PhD, Henrik Hasle, MD, Birgitte Lausen, MD PhD, Olafur G. Jonsson, MD PhD, Gitte Wulff Juergensen, MD, Lene Hyldahl Ebbesen, MD PhD, Florian Kuchenbauer, MD PhD, Erik Forestier, MD PhD, Jonas Abrahamsson, Linda Fogelstrand, MD PhD

Blood (2018) 132 (Supplement 1): 2814.

https://doi.org/10.1182/blood-2018-99-116618

Published: 2018

Journal Articles

Post-Therapy Measurable Residual Disease Monitoring in Peripheral Blood Using Overexpressed Genes in Childhood Acute Myeloid Leukemia

Anne-Sofie Skou, MD, Kristian Juul-Dam, MD, Maria Hansen, PhD MSc, Anni Aggerholm, MSc, PhD, Birgitte Lausen, MD PhD, Charlotte Guldborg Nyvold, Hans Beier Ommen, MD PhD, Henrik Hasle, MD

Blood (2018) 132 (Supplement 1): 1480.

https://doi.org/10.1182/blood-2018-99-110014

Published: 2018

Journal Articles

Features and Outcome of Chronic Myeloid Leukemia (CML) at Very Young Age: Data from the International Pediatric CML Registry (I-CML-Ped Study)

Adalet Meral Gunes, Frédéric Millot, MD, Krzysztof Kalwak, MD, Birgitte Lausen, MD PhD, Petr Sedlacek, MD, Birgitte Versluijs, Michael Dworzak, MD, Barbara De Moerloose, MD PhD, Meinolf Suttorp, PhD MD

Blood (2018) 132 (Supplement 1): 1748.

https://doi.org/10.1182/blood-2018-99-112905

Published: 2018

Journal Articles

Obesity Is Associated with Favorable Cytogenetic Abnormalities in Pediatric Acute Myeloid Leukemia

Ditte Juel Adolfsen Løhmann, MD, Jonas Abrahamsson, MD PhD, Shau-Yin Ha, MD PhD, Olafur G. Jonsson, MD PhD, Gertjan J.L. Kaspers, MD PhD, Minna M Koskenvuo, MD PhD, Birgitte Lausen, MD PhD, Barbara De Moerloose, MD PhD, Josefine Palle, MD PhD, Bernward Zeller, MD PhD, Henrik Hasle, MD PhD, Lillian Sung, MD PhD

Blood (2017) 130 (Supplement 1): 1302.

https://doi.org/10.1182/blood.V130.Suppl_1.1302.1302

Published: 2017

Journal Articles

Assessing the Subclonal Genetic Landscape of KMT2A -Rearranged Infant Acute Lymphoblastic Leukemia By Single-Cell Genomics

Mattias Pilheden, MSc, Axel Hyrenius Wittsten, MSc, Veronica Gonzalez-Pena, PhD, Helena Sturesson, PhD, Michael P Walsh, PhD, Guangchun Song, PhD, Hanne Vibeke Marquart, MD PhD, Birgitte Lausen, MD PhD, Anders Castor, MD PhD, Jinghui Zhang, PhD, James R. Downing, MD, Jing Ma, PhD, Charles Gawad, MD PhD, Anna K. Andersson, PhD

Blood (2017) 130 (Supplement 1): 2709.

https://doi.org/10.1182/blood.V130.Suppl_1.2709.2709

Published: 2017

Journal Articles

Host Genomic Variants and Risk of Infections During Induction Treatment in Childhood Acute Lymphoblastic Leukemia

Bendik Lund, Agata Wesolowska, Birgitte Lausen, MD, PhD, Louise Borst, Kirsten Kørup Rasmussen, Klaus Muller, MD, PhD, DMSc, Helge Klungland, Ramneek Gupta, Kjeld Schmiegelow

Blood (2012) 120 (21): 1382.

https://doi.org/10.1182/blood.V120.21.1382.1382

Published: 2012

Journal Articles

Genetic and Epigenetic Events in Childhood AML - Similarities and Differences with Adult AML.

Caroline Juhl-Christensen, MD, PhD, Hans Beier Ommen, MD, PhD, Anni Aggerholm, PhD, Birgitte Lausen, MD, PhD, Eigil Kjeldsen, MD, Henrik Hasle, MD, PhD, Peter Hokland, MD, DMSc

Blood (2009) 114 (22): 2396.

https://doi.org/10.1182/blood.V114.22.2396.2396

Published: 2009

Journal Articles

Impaired CD163 Mediated Hemoglobin-Scavenging and Hemolytic Crisis in Patients Treated with CD33 Targeted Chemotherapy (Gemtuzumab Ozogamicin, Mylotarg™).

Maciej B. Maniecki, MHSc, Henrik Hasle, MD, PHD, Lennart Friis-Hansen, MD, PHD, Birgitte Lausen, MD, PHD, Ove J. Nielsen, MD, PHD, Knud Bendix, MD, PHD, Soren K. Moestrup, MD, PHD, Holger J. Moller, MD, PHD

Blood (2007) 110 (11): 3684.

https://doi.org/10.1182/blood.V110.11.3684.3684

Published: 2007

NARROW

Quantification of Fusion Transcripts Reveals Slower Treatment Kinetics As Compared with Multiparameter Flow Cytometry during Induction Treatment of Acute Myeloid Leukemia in Children

Post-Therapy Measurable Residual Disease Monitoring in Peripheral Blood Using Overexpressed Genes in Childhood Acute Myeloid Leukemia

Features and Outcome of Chronic Myeloid Leukemia (CML) at Very Young Age: Data from the International Pediatric CML Registry (I-CML-Ped Study)

Obesity Is Associated with Favorable Cytogenetic Abnormalities in Pediatric Acute Myeloid Leukemia

Assessing the Subclonal Genetic Landscape of KMT2A -Rearranged Infant Acute Lymphoblastic Leukemia By Single-Cell Genomics

Host Genomic Variants and Risk of Infections During Induction Treatment in Childhood Acute Lymphoblastic Leukemia

Genetic and Epigenetic Events in Childhood AML - Similarities and Differences with Adult AML.

Impaired CD163 Mediated Hemoglobin-Scavenging and Hemolytic Crisis in Patients Treated with CD33 Targeted Chemotherapy (Gemtuzumab Ozogamicin, Mylotarg™).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only